Company Valuation: Exosens

Data adjusted to current consolidation scope
Fiscal Period: December 2024 2025 2026 2027 2028
Market Cap 1 986.7 2,459 2,958 - -
Change - 149.26% 20.27% - -
Enterprise Value (EV) 1 1,131 2,657 3,113 3,046 2,962
Change - 134.98% 17.14% -2.13% -2.76%
P/E 31.9x 57.7x 35.2x 25.5x 21.5x
PBR 2.39x 5.51x 5.76x 4.89x 4.15x
PEG 0x 1.5x 0.4x 0.7x 1.1x
Capitalization / Revenue 2.5x 5.25x 5.23x 4.62x 4.11x
EV / Revenue 2.87x 5.68x 5.51x 4.76x 4.11x
EV / EBITDA 9.54x 17.5x 16.6x 14.2x 12x
EV / EBIT 11.9x 20.8x 20.4x 17x 14.4x
EV / FCF 20.4x 46.4x 49x 35.3x 26.3x
FCF Yield 4.9% 2.16% 2.04% 2.83% 3.81%
Dividend per Share 2 0.1 0.3 0.3822 0.5215 0.634
Rate of return 0.51% 0.62% 0.66% 0.9% 1.09%
EPS 2 0.61 0.84 1.652 2.275 2.707
Distribution rate 16.4% 35.7% 23.1% 22.9% 23.4%
Net sales 1 394.1 468.2 565.2 640 720.3
EBITDA 1 118.5 151.6 187.3 214.1 246
EBIT 1 95.3 127.6 152.4 179.5 205.6
Net income 1 30.7 42.7 81.74 114 134.9
Net Debt 1 144.1 197.7 154.6 88.38 4.297
Reference price 2 19.43 48.45 58.10 58.10 58.10
Nbr of stocks (in thousands) 50,783 50,762 50,911 - -
Announcement Date 03/03/25 23/02/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
35.17x5.51x16.62x0.66% 3.29B
35.28x6.5x27.24x0.59% 319B
30.9x2.89x17.17x1.53% 251B
25.66x1.7x12.65x1.8% 167B
31.78x4.65x19.44x1.08% 149B
-519.67x1.73x38.97x-.--% 146B
31.55x3.45x15.65x1.31% 145B
17.16x1.67x11.89x2.68% 121B
19.69x1.67x13.66x1.89% 90.41B
39.49x8.92x27.67x0.24% 86.76B
Average -25.30x 3.87x 20.10x 1.18% 147.8B
Weighted average by Cap. -24.26x 3.84x 21.03x 1.18%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Exosens

Historical PBR trend

Valuation ratios - PBR - Exosens

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Exosens

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Exosens


Year-on-year evolution of the Yield

Valuation ratios - Yield - Exosens